| Erel Laufer, MD | |
|
3129 Alternate 19, Dunedin, FL 34698-1503 | |
| (727) 400-4768 | |
| Not Available |
| Full Name | Erel Laufer |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 3129 Alternate 19, Dunedin, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962689505 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME41440 (Florida) | Primary |
| Entity Name | Ls Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629852744 PECOS PAC ID: 2062876600 Enrollment ID: O20230914001965 |
News Archive
Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.
Living cells inside the body could be placed under surveillance-their location and migration noninvasively tracked in real time over many days-using a new method developed by researchers at KAUST.
"After a week of international diplomacy, President Obama returns to Washington this week facing an even greater diplomatic challenge: nudging the large and controversial health-care reform package toward consensus on Capitol Hill," The Washington Post reports.
Consumer Watchdog and other plaintiffs are suing Anthem Blue Cross, the California insurer that recently told policyholders it would hike premiums by 39 percent, the Los Angeles Times reports. The paper says the suit, which could gain class-action status, alleges that Anthem has violated "state law by closing certain policies to new members while illegally offering remaining customers alternative plans with fewer benefits at higher rates" (Helfand, 3/2).
For many people, coronary artery disease, or CAD—the buildup of plaque in the heart's arteries—is an unfortunate part of aging. By studying the genetic makeup of those who manage to maintain clear arteries into old age, researchers have identified a possible genetic basis for the disease, as well as potential new opportunities to prevent it.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erel Laufer, MD 3129 Alternate 19, Dunedin, FL 34698-1503 Ph: (727) 542-7377 | Erel Laufer, MD 3129 Alternate 19, Dunedin, FL 34698-1503 Ph: (727) 400-4768 |
News Archive
Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.
Living cells inside the body could be placed under surveillance-their location and migration noninvasively tracked in real time over many days-using a new method developed by researchers at KAUST.
"After a week of international diplomacy, President Obama returns to Washington this week facing an even greater diplomatic challenge: nudging the large and controversial health-care reform package toward consensus on Capitol Hill," The Washington Post reports.
Consumer Watchdog and other plaintiffs are suing Anthem Blue Cross, the California insurer that recently told policyholders it would hike premiums by 39 percent, the Los Angeles Times reports. The paper says the suit, which could gain class-action status, alleges that Anthem has violated "state law by closing certain policies to new members while illegally offering remaining customers alternative plans with fewer benefits at higher rates" (Helfand, 3/2).
For many people, coronary artery disease, or CAD—the buildup of plaque in the heart's arteries—is an unfortunate part of aging. By studying the genetic makeup of those who manage to maintain clear arteries into old age, researchers have identified a possible genetic basis for the disease, as well as potential new opportunities to prevent it.
› Verified 8 days ago
Jared Max Gopman, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3129 Alternate 19, Dunedin, FL 34698 Phone: 727-400-4768 | |
Tomasz Roman Kosowski, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3129 Alternate 19, Dunedin, FL 34698 Phone: 305-988-0898 Fax: 727-265-3420 |